Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: A randomised, double-blind trial

Lancet

Volumn 360, Issue 9347, 2002, Pages 1722-1727

  Khan, Wasif A ^a   Saha, Debasish ^a   Rahman, Anisur ^a   Salam, Mohammed A ^a   Bogaerts, Joseph ^a   Bennish, Michael L ^b,c,d  

^a ICDDRB Clinical Sciences Division   (Bangladesh)

^b AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN;

ADOLESCENT; ANOREXIA; ARTICLE; BACTERIUM CULTURE; CHILD; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FECES ANALYSIS; FEMALE; FLUID BALANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIBRIO CHOLERAE; VOMITING;

EID: 0037202862     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11680-1     Document Type: Article

References (31)

1. Anon. Cholera, 2000. Wkly Epidemiol Rec 2001; 76: 233-40.
2. Bennish M.L. Cholera: pathophysiology, clinical features, and treatment. Wachsmuth I.K., Blake P.A., Olsvik O. Vibrio cholerae and cholera: molecular to global perspectives. 1994;229-255 American Society for Microbiology, Washington.
3. Ryan E.T., Dhar U., Khan W.A., et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 63:2000;12-20.
4. Greenough W.B. III, Gordon R.S., Rosenberg I.S., Davies B.I., Benenson A.S. Tetracycline in the treatment of cholera. Lancet. 1:1964;355-357.
5. Roy S.K., Islam A., Ali R., et al. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Trans R Soc Trop Med Hyg. 92:1998;460-462.
6. Khan W.A., Begum M., Salam M.A., Bardhan P.K., Islam M.R., Mahalanabis D. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults. Trans R Soc Trop Med Hyg. 89:1995;103-106.
7. Sack D.A., Islam S., Rabbani H., Islam A. Single-dose doxycycline for cholera. Antimicrob Agents Chemother. 14:1978;462-464.
8. Rabbani G.H., Islam M.R., Butler T., Shahrier M., Alam K. Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial. Antimicrob Agents Chemother. 33:1989;1447-1450.
9. Islam M.R. Single dose tetracycline in cholera. Gut. 28:1987;1029-1032.
10. Alam A.N., Alam N.H., Ahmed T., Sack D.A. Randomised double blind trial of single dose doxycycline for treating cholera in adults. BMJ. 300:1990;1619-1621.
11. Khan W.A., Bennish M.L., Seas C., et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139. Lancet. 348:1996;296-300.
12. Rabbani G.H., Butler T., Shahrier M., Mazumdar R., Islam M.R. Efficacy of a single dose of furazolidone for treatment of cholera in children. Antimicrob Agents Chemother. 35:1991;1864-1867.
13. WHO. Management of the Patient with Cholera. Geneva: World Health Organization, 1991: 1-11.
14. Bennish M.L., Levy S.B. Antimicrobial resistance of enteric pathogens. Blaser J.M., Smith P.D., Ravdin J.I., Greenberg H.B., Guerrant R.L. Infections of the gastrointestinal tract. 1995;1499-1523 Raven Press, New York.
15. Foulds G., Luke D.R., Teng R., Willavize S.A., Friedman H., Curatolo W.J. The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. J Antimicrob Chemother. 37:(suppl C):1996;37-44.
16. Nahata M.C., Koranyi K.I., Gadgil S.D., Hilligoss D.M., Fouda H.G., Gardner M.J. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents Chemother. 37:1993;314-316.
17. Treadway G., Pontani D. Paediatric safety of azithromycin: worldwide experience. J Antimicrob Chemother. 37:(suppl C):1996;143-149.
18. Bailey R.L., Arullendran P., Whittle H.C., Mabey D.C. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 342:1993;453-456.
19. Martin D.H., Mroczkowski T.F., Dalu Z.A., et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med. 327:1992;921-925.
20. Salam M.A., Bennish M.L. Therapy for shigellosis, 1: randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr. 113:1988;901-907.
21. Simon H.J., Yin E.J. Microbioassay of antimicrobial agents. Appl Microbiol. 19:1970;573-579.
22. Makuch R.W., Johnson M.F. Some issues in the design and interpretation of 'negative' clinical studies. Arch Intern Med. 146:1986;986-989.
23. Lindenbaum J., Greenough W.B., Islam M.R. Antibiotic therapy of cholera in children. Bull World Health Organ. 37:1967;529-538.
24. Karchmer A.W., Curlin G.T., Huq M.I., Hirschhorn N. Furazolidone in paediatric cholera. Bull World Health Organ. 43:1970;373-378.
25. Kabir I., Khan W.A., Haider R., Mitra A.K., Alam A.N. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. J Diarrhoeal Dis Res. 14:1996;243-247.
26. Siddique A.K., Salam A., Islam M.S., et al. Why treatment centres failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire. Lancet. 345:1995;359-361.
27. Khan W.A., Seas C., Dhar U., Salam M.A., Bennish M.L. Treatment of shigellosis, 5: comparison of azithromycin and ciprofloxacin - a double-blind, randomized, controlled trial. Ann Intern Med. 126:1997;697-703.
28. World Bank. Data and statistics, 2002. http://www.worldbank.org/data/countrydata/countrydata.html (accessed July 25, 2002).
29. Salam M.A., Dhar U., Khan W.A., Bennish M.L. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet. 352:1998;522-527.
30. Lindenbaum J., Akbar R., Gordon R.S. Jr, Greenough W.B., Hirschorn N., Islam M.R. Cholera in children. Lancet. 1:1966;1066-1068.
31. Bonetta L. Pediatric study of medicines becomes mandatory. Nat Med. 6:2000;1069.